Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Receivables (2020 - 2025)

Sight Sciences has reported Change in Receivables over the past 6 years, most recently at $102000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at $102000.0 for Q4 2025, up 104.82% from a year ago — trailing twelve months through Dec 2025 was -$912000.0 (up 74.27% YoY), and the annual figure for FY2025 was -$912000.0, up 74.27%.
  • Change in Receivables for Q4 2025 was $102000.0 at Sight Sciences, up from $98000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for SGHT hit a ceiling of $4.3 million in Q2 2024 and a floor of -$7.2 million in Q3 2024.
  • Median Change in Receivables over the past 5 years was $495500.0 (2021), compared with a mean of $270850.0.
  • Biggest five-year swings in Change in Receivables: surged 19800.0% in 2022 and later crashed 786.26% in 2024.
  • Sight Sciences' Change in Receivables stood at -$13000.0 in 2021, then surged by 19800.0% to $2.6 million in 2022, then crashed by 211.21% to -$2.8 million in 2023, then increased by 25.63% to -$2.1 million in 2024, then soared by 104.82% to $102000.0 in 2025.
  • The last three reported values for Change in Receivables were $102000.0 (Q4 2025), $98000.0 (Q3 2025), and $215000.0 (Q2 2025) per Business Quant data.